146 related articles for article (PubMed ID: 32533632)
1. Identification and characterization of a Triton X-100 replacement for virus inactivation.
Luo W; Hickman D; Keykhosravani M; Wilson J; Fink J; Huang L; Chen D; O'Donnell S
Biotechnol Prog; 2020 Nov; 36(6):e3036. PubMed ID: 32533632
[TBL] [Abstract][Full Text] [Related]
2. Insights into virus inactivation by polysorbate 80 in the absence of solvent.
Chen D; Luo W; Hoffman J; Huang L; Sandefur S; Hall T; Murphy M; O'Donnell S
Biotechnol Prog; 2020 May; 36(3):e2953. PubMed ID: 31846227
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of the 2023 Viral Clearance Symposium, Session 6: Viral Inactivation.
Ma J; Roush D
PDA J Pharm Sci Technol; 2024; 78(2):187-195. PubMed ID: 38609155
[TBL] [Abstract][Full Text] [Related]
4. Supported Lipid Bilayer Platform for Characterizing the Membrane-Disruptive Behaviors of Triton X-100 and Potential Detergent Replacements.
Gooran N; Yoon BK; Jackman JA
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055053
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of "Nereid," a new phenol-free detergent to replace Triton X-100 in virus inactivation.
Farcet JB; Kindermann J; Karbiener M; Scheinecker R; Kostner O; Kreil TR
J Med Virol; 2021 Jun; 93(6):3880-3889. PubMed ID: 33274764
[TBL] [Abstract][Full Text] [Related]
7. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
8. Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC.
Farcet JB; Karbiener M; Zelger L; Kindermann J; Kreil TR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175626
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity.
Colavita F; Quartu S; Lalle E; Bordi L; Lapa D; Meschi S; Vulcano A; Toffoletti A; Bordi E; Paglia MG; Di Caro A; Ippolito G; Capobianchi MR; Castilletti C
J Clin Virol; 2017 Jan; 86():27-30. PubMed ID: 27912126
[TBL] [Abstract][Full Text] [Related]
10. Identification of compendial nonionic detergents for the replacement of Triton X-100 in bioprocessing.
Hunter AK; Rezvani K; Aspelund MT; Xi G; Gadre D; Linke T; Cai K; Mulagapati SHR; Witkos T
Biotechnol Prog; 2022 Mar; 38(2):e3235. PubMed ID: 35043591
[TBL] [Abstract][Full Text] [Related]
11. Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes.
Feroz H; Chennamsetty N; Byers S; Holstein M; Li ZJ; Ghose S
Biotechnol Bioeng; 2022 Apr; 119(4):1091-1104. PubMed ID: 35023152
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the 2019 Viral Clearance Symposium, Session 5: Viral Inactivation.
Ma J
PDA J Pharm Sci Technol; 2022; 76(4):339-348. PubMed ID: 34911831
[TBL] [Abstract][Full Text] [Related]
13. Tethered Bilayer Lipid Membrane Platform for Screening Triton X-100 Detergent Replacements by Electrochemical Impedance Spectroscopy.
Tan SW; Gooran N; Lim HM; Yoon BK; Jackman JA
Nanomaterials (Basel); 2023 Feb; 13(5):. PubMed ID: 36903751
[TBL] [Abstract][Full Text] [Related]
14. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
15. Single-use technology for solvent/detergent virus inactivation of industrial plasma products.
Hsieh YT; Mullin L; Greenhalgh P; Cunningham M; Goodrich E; Shea J; Youssef E; Burnouf T
Transfusion; 2016 Jun; 56(6):1384-93. PubMed ID: 27125447
[TBL] [Abstract][Full Text] [Related]
16. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
17. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Dichtelmüller HO; Biesert L; Fabbrizzi F; Gajardo R; Gröner A; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Pifat D; Osheroff W; Poelsler G
Transfusion; 2009 Sep; 49(9):1931-43. PubMed ID: 19497061
[TBL] [Abstract][Full Text] [Related]
18. Ebola Virus Inactivation by Detergents Is Annulled in Serum.
van Kampen JJA; Tintu A; Russcher H; Fraaij PLA; Reusken CBEM; Rijken M; van Hellemond JJ; van Genderen PJJ; Koelewijn R; de Jong MD; Haddock E; Fischer RJ; Munster VJ; Koopmans MPG
J Infect Dis; 2017 Oct; 216(7):859-866. PubMed ID: 28961947
[TBL] [Abstract][Full Text] [Related]
19. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.
Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M
Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391
[TBL] [Abstract][Full Text] [Related]
20. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
